Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Women with PCOS may be more likely to have gum disease than healthy women.

Women with hair loss may benefit from higher iron levels.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Some medications can help increase sexual desire and function in women.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Women with PCOS are more likely to experience depressive symptoms.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Hirsutism in Afghan women varies by community, influenced by awareness, education, and socio-economic status.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.